GE HealthCare reports Q1 2024 results: revenue flat organically, margins expand, reaffirms guidance

GE HealthCare Technologies Inc.

2024-Q1 EPS reported $0.81 revenue$4,650,000,000

Revenues declined 1% to $4.6B; organic revenue approximately flat year-over-year.
Net income margin improved to 8.0% from 7.9%; Adjusted EBIT margin rose to 14.7% from 14.1%.
Diluted EPS increased to $0.81 from $0.41; Adjusted EPS rose to $0.90 from $0.85.
Cash from operations $419M vs $468M; free cash flow $274M vs $325M; repaid $150M debt.
Reaffirmed full-year 2024 guidance: ~4% organic revenue growth, Adjusted EPS $4.20-$4.35.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

GE HealthCare Technologies Inc. reported the first quarter ended March 31, 2024 results: revenue $4.6 billion, net income $374 million, EPS $0.81. Guidance reaffirmed.

Period: the first quarter ended March 31, 2024
Revenue: $4.6 billion
Net income: $374 million
EPS: $0.81
Guidance: reaffirmed
Result: reported results

Exact text from the filing

of 2024 consistent with our previous comments, and we remain on track to deliver our guidance for the year.” First Quarter 2024 Total Company Financial Performance • Revenues of $4.6 billion declined 1% r eported and were approximately flat on an Organic* basis year-over-year, with decreased volume partially offset by positive price. • Total company book-to-bill was

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-24-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.